Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects:: the role of timing of onset of GHD

被引:34
作者
Lissett, CA
Jönsson, P
Monson, JP
Shalet, SM [1 ]
机构
[1] Christie Hosp, Dept Endocrinol, Manchester M20 4BX, Lancs, England
[2] KIGS KIMS Outcomes Res Pharmacia, Stockholm, Sweden
[3] St Bartholomews Hosp, London, England
关键词
D O I
10.1046/j.1365-2265.2003.01884.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND IGF-I standard deviation score (SDS) is widely used in clinical practice; however, factors determining IGF-I SDS in GH-deficient (GHD) individuals remain incompletely understood. Earlier studies have been limited by the small size of cohorts studied. We have used the KIMS database to examine if a true difference exists between subjects who developed GHD in adult life (AO), and those who developed GHD in childhood (CO). PATIENTS A total of 1317 patients fulfilled the inclusion criteria, 1073 with AO GHD and 244 with CO GHD. METHODS Serum IGF-I concentrations were determined by a hydrochloric acid-ethanol extraction radioimmunoassay method using synthetic IGF-I for labelling. The reference range was calculated using normative data from healthy Swedish individuals. RESULTS A total of 86% of patients with CO GHD but only 52% of patients with AO GHD had IGF-I SDS below -2 SDS. The CO cohort had a lower IGF-I SDS (-4.69 vs.-2.24, P < 0.0001), a smaller body mass index (BMI; 26.6 vs. 28.6 kg/m(2), P < 0.0001) and waist-hip ratio (WHR; 0.90 vs. 0.92 P < 0.001) than the AO cohort. A stepwise multiple linear regression was performed to examine the principal determinants of IGF-I SDS. Age at onset of GHD was the most important determinant of IGF-I SDS, contributing 17% towards the variability of IGF-I SDS. Timing of onset, gender, BMI, and number of pituitary hormone deficiencies other than GH deficiency were also significant determinants of IGF-I SDS. CONCLUSION Whilst age at onset of GHD was the most important determinant of IGF-I SDS, individuals with CO GHD had values on average 1.43 lower than those with AO GHD, all other factors being equal. Potential explanations include differences in GH secretory patterns, variation in body composition, and/or suboptimal treatment of GHD in childhood.
引用
收藏
页码:773 / 778
页数:6
相关论文
共 19 条
[1]   Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults [J].
Aimaretti, G ;
Corneli, G ;
Razzore, P ;
Bellone, S ;
Baffoni, C ;
Bellone, J ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (08) :506-511
[2]   Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment [J].
Attanasio, AF ;
Lamberts, SWJ ;
Matranga, AMC ;
Birkett, MA ;
Bates, PC ;
Valk, NK ;
Hilsted, J ;
Bengtsson, BA ;
Strasburger, CJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :82-88
[3]   Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severelv GH-deficient (GHD) patients after childhood GH treatment: A comparison with adult onset GFID patients [J].
Attanasio, AF ;
Howell, S ;
Bates, PC ;
Frewer, P ;
Chipman, J ;
Blum, WF ;
Shalet, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) :3368-3372
[4]  
BESHYAH SA, 1994, ENDOCRINOL METAB, V1, P167
[5]   Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects [J].
Hilding, A ;
Hall, K ;
Wivall-Helleryd, IL ;
Sääf, M ;
Mellin, AL ;
Thorén, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :2013-2019
[6]   FACTORS INFLUENCING THE DESIRE FOR LONG-TERM GROWTH-HORMONE REPLACEMENT IN ADULTS [J].
HOLMES, SJ ;
SHALET, SM .
CLINICAL ENDOCRINOLOGY, 1995, 43 (02) :151-157
[7]   A low starting dose of genotropin in growth hormone-deficient adults [J].
Janssen, YJH ;
Frolich, M ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :129-135
[8]   Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects [J].
Jorgensen, JOL ;
Vahl, N ;
Hansen, TB ;
Skjaerbaek, C ;
Fisker, S ;
Orskov, H ;
Hagen, C ;
Christiansen, JS .
CLINICAL ENDOCRINOLOGY, 1998, 48 (04) :479-486
[9]   THE PROLACTIN GROWTH-HORMONE RECEPTOR FAMILY [J].
KELLY, PA ;
DJIANE, J ;
POSTELVINAY, MC ;
EDERY, M .
ENDOCRINE REVIEWS, 1991, 12 (03) :235-251
[10]   Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset:: A comparative, prospective study [J].
Koranyi, J ;
Svensson, J ;
Götherström, G ;
Sunnerhagen, KS ;
Bengtsson, BÅ ;
Johannsson, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4693-4699